Modern approaches to pharmacotherapy of non-alcoholic fatty liver disease-Reference-Cited by-同舟云学术

Modern approaches to pharmacotherapy of non-alcoholic fatty liver disease

Published:2021-02-01 Issue:2 Volume: Page:48-64
ISSN:2074-9600
Container-title:Spravočnik vrača obŝej praktiki (Journal of Family Medicine)
language:ru
Short-container-title:

Author:

Maksimov Maksim Leonidovich¹,Zvegintseva Albina Airatovna²,Shindina Tatyana Sergeevna³

Affiliation:

1. FSBEI FPE RMACPE, FSAEI HE Kazan (Volga Region) Federal University

2. SAHI Republican Clinical Hospital

3. FSBI Polyclinic No. 5 of the Presidential Administration of the Russian Federation

Abstract

According to the forecasts of the World Health Organization, non-alcoholic fatty liver disease (NAFLD) will rank first in the structure of liver diseases by 2020. The article presents the current provisions on the pathogenesis of NAFLD, as well as existing and promising directions in the treatment of non-alcoholic fatty liver disease. A review of the recommendations of the leading hepatological associations for the treatment of non-alcoholic fatty liver disease is carried out. The main directions in the pharmacological treatment of NAFLD are the prescription of drugs that reduce body weight, increase the sensitivity of tissues to insulin, affect oxidative stress, normalize the levels of lipids and blood transaminases, and correct intestinal microflora.

Publisher

PANORAMA Publishing House

Reference52 articles.

1. Ludwig J., Viggiano T.R. Non — alcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease // Mayo Clin Proc. 1980. Vol. 55. Р. 434–438.

2. Masharova A.A., Danilevskaia N.N. Nealkogolnyi steatogepatit: ot patogeneza k terapii [Nonalcoholic steatohepatitis: from pathogenesis to therapy]. 2013. — No. 31. — P. 1642. (In Russ.)

3. Bueverov A.O., Bogomolov P.O. Nealkogolnaia zhirovaia bolezn pecheni: obosnovanie patogeneticheskoi terapii [Non-alcoholic fatty liver disease: justification of pathogenetic therapy] // Klin. persp. gastroenterol. gepatol. [Clinical perspective of gastroenterol. hepatol.] 2009. No. 1. P. 3–9. (In Russ.)

4. Korneeva O.N., Drapkina O.M., Bueverov A.O., Ivashkin V.T. Nealkogolnaia zhirovaia bolezn pecheni kak proiavlenie metabolicheskogo sindroma [Non-alcoholic fatty liver disease as a manifestation of metabolic syndrome] // Klin. persp. gastroenterol. gepatol. [Clinical perspective of gastroenterol. hepatol.] 2005. No. 4. P. 21–24. (In Russ.)

5. Kropova O.E., Shindina T.S., Maksimov M.L. Nealkogolnaia zhirovaia bolezn pecheni: faktory riska i patogeneticheskaia terapiia [Non-alcoholic fatty liver disease: risk factors and pathogenetic therapy]. RMZh [Russian medical journal]. 2016. — No. 26. — P. 1801–1804. (In Russ.)